COCHLEAR LIMITED ADR
WKN: A1C3B8 | ISIN: US1914592050 | Ticker-Symbol: OC50Siehe auch COCHLEAR LIMITED
Frankfurt
02.01.26 | 08:07
73,00 Euro
-1,35 % -1,00
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 73,50 | 75,50 | 03.01. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.12.25 | COCHLEAR LIMITED: Notification of cessation of securities - COH | - | ASX | ||
| 18.12.25 | COCHLEAR LIMITED: Notification regarding unquoted securities - COH | - | ASX | ||
| 18.12.25 | Envoy Medical, Inc.: Envoy Medical Reaches Enrollment Milestone in Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant | 180 | Newsfile | White Bear Lake, Minnesota--(Newsfile Corp. - December 18, 2025) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing... ► Artikel lesen | |
| COCHLEAR LIMITED ADR Aktie jetzt für 0€ handeln | |||||
| 16.12.25 | Envoy Medical, Inc.: Envoy Medical Secures New Australian Patent for Cochlear Implant Innovation Aimed at Enhancing Input Signal-to-Noise Ratio | 191 | Newsfile | White Bear Lake, Minnesota--(Newsfile Corp. - December 16, 2025) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing... ► Artikel lesen | |
| 10.12.25 | Envoy Medical, Inc.: Envoy Medical Completes First Set of Activations in Final Stage of Pivotal Clinical Study for its First-Of-Its-Kind Fully Implanted Acclaim(R) Cochlear Implant | 269 | Newsfile | White Bear Lake, Minnesota--(Newsfile Corp. - December 10, 2025) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing... ► Artikel lesen | |
| 04.12.25 | Envoy Medical, Inc.: Envoy Medical to Host Fireside Chat with CEO Brent Lucas and the First Acclaim(R) Cochlear Implant Patient | 249 | Newsfile | White Bear Lake, Minnesota--(Newsfile Corp. - December 4, 2025) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions... ► Artikel lesen | |
| 02.12.25 | Cochlear-aligned biotech off to a lacklustre start on the ASX | 6 | The Motley Fool Australia | ||
| 25.11.25 | Biocurious: Cochlear-backed Epiminder strives to raise the bar on epilepsy monitoring | 2 | Stockhead | ||
| 21.11.25 | Cochlear baut Produktmanagement aus | 4 | new business | ||
| 20.11.25 | Envoy Medical, Inc.: Envoy Medical Secures New U.S. Patent for Innovative Cochlear Implant System Featuring a Removable Earplug Sensor and an Implanted Battery | 407 | Newsfile | White Bear Lake, Minnesota--(Newsfile Corp. - November 20, 2025) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing... ► Artikel lesen | |
| 20.11.25 | Cochlear Implant Surgery Reduces Dementia Risk by Two-thirds | 5 | BusinessKorea | ||
| 18.11.25 | Envoy Medical, Inc.: Envoy Medical Achieves Six-Month Milestone with First 10 Patients in Acclaim(R) Cochlear Implant Clinical Trial | 246 | Newsfile | White Bear Lake, Minnesota--(Newsfile Corp. - November 18, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing... ► Artikel lesen | |
| 17.11.25 | COCHLEAR LIMITED: Change in substantial holding | 1 | ASX | ||
| 12.11.25 | COCHLEAR LIMITED: Appendix 3Y - Diggory Howitt | - | ASX | ||
| 12.11.25 | COCHLEAR LIMITED: Notification regarding unquoted securities - COH | - | ASX | ||
| 12.11.25 | COCHLEAR LIMITED: Ceasing to be a substantial holder | - | ASX | ||
| 12.11.25 | This Cochlear-backed ASX aspirant will be targeting an epilepsy market worth north of $1 billion | 2 | The Motley Fool Australia | ||
| 05.11.25 | COCHLEAR LIMITED: Becoming a substantial holder | - | ASX | ||
| 04.11.25 | Envoy Medical, Inc.: Envoy Medical Announces First Three Patients Enrolled in Final Stage of Acclaim(R) Cochlear Implant Pivotal Clinical Trial | 401 | Newsfile | White Bear Lake, Minnesota--(Newsfile Corp. - November 4, 2025) - Envoy Medical, Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing... ► Artikel lesen | |
| 29.10.25 | Envoy Medical, Inc.: Envoy Medical Marks Three-Year Anniversary of First Patient Receiving Its Breakthrough Fully Implanted Cochlear Implant | 314 | Newsfile | White Bear Lake, Minnesota--(Newsfile Corp. - October 29, 2025) - Envoy Medical, Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing... ► Artikel lesen |
1 2 3 4 Weiter >>
79 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 47,730 | -2,55 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,170 | -1,45 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 44,140 | -1,74 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers vor Zahlen zum ersten Geschäftsquartal auf "Buy" mit einem Kursziel von 60 Euro belassen. Der Medizintechnikkonzern... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 39,620 | -0,95 % | Carl Zeiss Meditec mit BREAKING NEWS! | ||
| ECKERT & ZIEGLER | 15,010 | -1,64 % | ECKERT & ZIEGLER SE - Stabilität als strategische Basis | ||
| MEDTRONIC | 81,89 | -0,11 % | Bearish Options Activity Emerges on Medtronic plc (MDT) Despite Long-Term Growth Outlook | ||
| INTUITIVE SURGICAL | 479,80 | +0,07 % | Where Will Intuitive Surgical Be in 5 Years? | ||
| TELADOC HEALTH | 5,977 | -0,60 % | Teladoc Health, Inc.: Teladoc Health Announces Chief Financial Officer Transition | NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced that Mala Murthy will be stepping down from her role as Chief Financial... ► Artikel lesen | |
| STRAUMANN | 101,85 | -0,15 % | AKTIEN IM FOKUS: Medizintechnikwerte von Exane bewegt - 'Zweigeteiltes 2026' | FRANKFURT (dpa-AFX) - Die Aktien von Siemens Healthineers und Sartorius haben am Mittwoch nach einer Studie von Exane BNP Paribas zum europäischen Medizintechniksektor unterschiedliche Richtungen eingeschlagen.... ► Artikel lesen | |
| DEXCOM | 56,57 | -0,39 % | DexCom, Inc.: Listening to Healthcare Professionals: Dexcom Launches New Education Offering, Dexcom Academy | New personalised learning platform aims to build confidence in healthcare professional (HCP) CGM knowledge, no matter their previous experience, and support high-quality diabetes care. ... ► Artikel lesen | |
| ALIGN TECHNOLOGY | 133,05 | -0,11 % | TECX, GKOS, GH, ALGN, NMRA Surge After Hours On Clinical Data And Earnings | WASHINGTON (dpa-AFX) - Several healthcare and life sciences names posted notable gains in after-hours trading, driven by clinical updates, earnings releases, and in some cases, unexplained momentum.Tectonic... ► Artikel lesen | |
| HENRY SCHEIN | 64,34 | -1,86 % | Henry Schein to announce next CEO by mid-January | ||
| TANDEM DIABETES | 18,875 | +2,58 % | TANDEM DIABETES CARE INC - 8-K, Current Report | ||
| INSULET | 240,10 | -0,54 % | Is it the Right Time to Add Insulet Stock to Your Portfolio? | ||
| AMBU | 11,590 | 0,00 % | Dividendenbekanntmachungen (04.12.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AGEAS SA/NV ADR US00844W2089 1,7428 USD 1,4932 EUR AIR LEASE CORPORATION US00912X3026 0,22 USD 0,1884 EUR ALAMOS GOLD INC CA0115321089 0... ► Artikel lesen |
COCHLEAR LIMITED ADR gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -1,00 (-1,35 %) liegt der Kurs bei 73,00 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu COCHLEAR LIMITED ADR finden Sie auf Wallstreet Online.